Genetic evidence for a causal relationship between melatonin metabolism and depression.
Yuanbi Wang, Wen Wen, Hansheng Chen et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review utilized two-sample Mendelian randomization to explore the causal relationship between melatonin metabolism and specific depression symptom subtypes in major depressive disorder (MDD). The study found that the genetically proxied synthesis route was associated with a reduced risk of PHQ9A5 (OR: 0.89), while higher brain melatonin degradation increased the risk of several symptoms, including PHQ9A1 and PHQ9A7 (OR: 1.03).
Key findings
- Genetically proxied synthesis-route signal associated with PHQ9A5 (OR: 0.89, 95% CI: 0.85-0.93).
- Higher brain melatonin degradation raised the risk of PHQ9A1 (OR: 1.03, 95% CI: 1.02-1.04).
- Up-regulation of the kynurenine sub-pathway increased odds of PHQ9A3 (OR: 1.05, 95% CI: 1.02-1.07).
- SULT1A1 expression showed varying effects on different PHQ-9 symptom subtypes.
Why it matters
Understanding the causal relationship between melatonin metabolism and depression symptom subtypes can inform treatment strategies. This knowledge may guide clinicians in optimizing melatonin supplementation for patients with specific depressive symptoms.